Amy Harmon, a science writer for the New York Times, writes “Gene Map Becomes a Luxury Item,” an article about Knome (know-me), a sequencing company that will return a customer’s entire genomic sequence for $350,000. Knome was co-founded by Harvard professor George Church, who also directs the Personal Genome Project.
Dan Stoicescu is a retired millionaire who has recently become Knome’s first customer, and only the second person in the world to purchase his entire genomic sequence. According to Dr. Stoicescu, he understands that as of today there is little that his sequence will reveal, but he plans to compare the results of new studies to his genome daily, “like a stock portfolio.”
The article also reveals that Illumina is planning “to sell whole genome sequencing to the ‘rich and famous market’ this year,” says chief executive Jay Flatley. This probably won’t pose much of a problem to Knome – the founders have stated that they are only “offering 20 individuals the opportunity to participate in [their] initial launch phase.”
The “Starting a Business” section of the online bizjournals site has an article called “Riding the Revolution” that reviews the success of the entrepreneurs behind the popular Family Tree DNA (who recently launched a new company called DNATraits).
The company was founded in April 2000 and is led by president Bennett Greenspan and chief operating officer Max Blankfeld. As the article details, the company has grown from $2.6 million in revenue in 2004 to $12.2 million in 2006, an incredibly impressive climb.
Part of the article describes the company’s future directions and challenges:
“The best solution to building an infrastructure is to be proactive, Blankfeld says, in areas such as human resources, technology and research and development. ‘We hired and keep hiring good people, whether for customer service or the lab; we invested in state-of-the-art equipment for the lab and we keep developing new tests that will respond to our customers’ needs,’ he says.”
Family Tree DNA announces a new SNP product for members of the R1b Y-chromosome haplogroup. The following was posted at the DNA-NEWBIE Yahoogroup by Max Blankfeld, Vice-President of Operations and Marketing at FTDNA:
Many of you have asked about, and have quoted Bennett Greenspanâ€™s comment at the 4th Annual FTDNA Conference on Genetic Genealogy, that in early 2008 weâ€™d be offering the R1b U SNPâ€™s, known as U106 and U152 (also called: S21/S28). We are pleased to announce today that a mini panel containing those SNPâ€™s (as well as U198 and P107) are now available.
Previously, FTDNA could SNP test for R1b1c1 through R1b1c8, but was not testing for R1b1c9, R1b1c10, or R1b1c11. The new SNPs will test for R1b1c9 (U106), R1b1c9b (U198), and R1b1c10 (U152). The P107 SNP is a private SNP within R1b1c9. The R1b tree is available through ISOGG:
R1b1c9 – U106
R1b1c9a – not yet tested
R1b1c9b – U198
R1b1c10 – U152
According to sources, the new SNPs will be worked into the R1b SNP package in the next few weeks, but it is already available for those who have previously undergone R1b SNP analysis.